You are here: Industry Insights > WuXi

News List

Wuxi Strives to Build a World-class Biomedical Industry Chain prnasia
April 23, 2021
From April 21 to 23, the 2021 Taihu Bay Future Healthcare Conference was held in Wuxi, China. More than 160 experts including Hejie, Fan Chunhai and many other academicians carried out forward-looking, authoritative, and predictive exchanges and ...
AstraZeneca launches health innovation hub in Wuxi biospectrumasia
September 20, 2019
AstraZeneca’s Wuxi innovation story began back in 2017 with the creation of the Healthcare Internet of Things Innovation Center, established to explore innovative new treatment options and to seek out opportunities for integrating digital solutions into t
WuXi STA Facilities Pass U.S. FDA Inspections contractpharma
July 25, 2019
Analytical Service Unit in Shanghai and API manufacturing facility in Changzhou successfully pass inspections.
WuXi Biologics Plans to Further Expand New Bioconjugation Center contractpharma
June 24, 2019
To include commercial manufacturing in Wuxi City, China.
Phoenix Molecular, WuXi STA Reach Drug Supply Milestone contractpharma
June 10, 2019
Completes clinical trial supply to support Phase I/Ib study of PMD-026 for TNBC.
WuXi Biologics Inks Strategic LOI with Global Vax Leader contractpharma
May 29, 2019
WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.
Jacobs to Provide Construction for WuXi Biologics Biomfg. Facility contractpharma
May 29, 2019
Plant to be WuXi's first outside of China and largest using single-use bioreactors in Ireland.
WuXi to build dedicated vaccine facility, but who's the client? fiercepharma
May 29, 2019
WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a contract that should produce $150 million a year for 20 years. It just didn’t identify the client.
WuXi Biologics to Build Mfg. Center in Southwest China contractpharma
May 17, 2019
Begins construction of a 48,000L Integrated Manufacturing Center for Innovative Biologics in Chengdu.
WuXi Biologics Completes First FDA Routine GMP Inspection contractpharma
May 16, 2019
Production of Trogarzo is now approved at the Wuxi facility.

Previous page 1 2 3 Next page